Goldman Sachs’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,731
| Closed | -$52.2K | – | 5276 |
|
|
2025
Q1 | $52.2K | Buy |
3,731
+1,083
| +41% | +$15.2K | ﹤0.01% | 4908 |
|
|
2024
Q4 | $44K | Buy |
2,648
+1,915
| +261% | +$31.8K | ﹤0.01% | 4860 |
|
|
2024
Q3 | $13.9K | Sell |
733
-32,615
| -98% | -$617K | ﹤0.01% | 4721 |
|
|
2024
Q2 | $483K | Sell |
33,348
-19,859
| -37% | -$287K | ﹤0.01% | 3974 |
|
|
2024
Q1 | $824K | Buy |
53,207
+31,414
| +144% | +$486K | ﹤0.01% | 3729 |
|
|
2023
Q4 | $610K | Sell |
21,793
-13,250
| -38% | -$371K | ﹤0.01% | 3847 |
|
|
2023
Q3 | $1.67M | Buy |
35,043
+2,203
| +7% | +$105K | ﹤0.01% | 3205 |
|
|
2023
Q2 | $3.15M | Buy |
32,840
+16,803
| +105% | +$1.61M | ﹤0.01% | 2900 |
|
|
2023
Q1 | $1.82M | Sell |
16,037
-683
| -4% | -$77.5K | ﹤0.01% | 3280 |
|
|
2022
Q4 | $1.87M | Buy |
16,720
+3,443
| +26% | +$386K | ﹤0.01% | 3321 |
|
|
2022
Q3 | $1.71M | Sell |
13,277
-10,300
| -44% | -$1.32M | ﹤0.01% | 3467 |
|
|
2022
Q2 | $1.62M | Sell |
23,577
-7,850
| -25% | -$539K | ﹤0.01% | 3603 |
|
|
2022
Q1 | $4.48M | Sell |
31,427
-30,496
| -49% | -$4.34M | ﹤0.01% | 2889 |
|
|
2021
Q4 | $10.3M | Buy |
61,923
+33,347
| +117% | +$5.56M | ﹤0.01% | 2247 |
|
|
2021
Q3 | $3.98M | Sell |
28,576
-7,549
| -21% | -$1.05M | ﹤0.01% | 2948 |
|
|
2021
Q2 | $17.2M | Sell |
36,125
-9,331
| -21% | -$4.45M | ﹤0.01% | 1847 |
|
|
2021
Q1 | $18.7M | Buy |
45,456
+8,225
| +22% | +$3.39M | ﹤0.01% | 1728 |
|
|
2020
Q4 | $18.2M | Buy |
37,231
+32,601
| +704% | +$16M | ﹤0.01% | 1628 |
|
|
2020
Q3 | $2.62M | Sell |
4,630
-13,690
| -75% | -$7.75M | ﹤0.01% | 2756 |
|
|
2020
Q2 | $1.74M | Buy |
18,320
+9,991
| +120% | +$951K | ﹤0.01% | 2912 |
|
|
2020
Q1 | $594K | Buy |
8,329
+136
| +2% | +$9.7K | ﹤0.01% | 3403 |
|
|
2019
Q4 | $565K | Buy |
8,193
+2,476
| +43% | +$171K | ﹤0.01% | 3592 |
|
|
2019
Q3 | $459K | Sell |
5,717
-25,663
| -82% | -$2.06M | ﹤0.01% | 3632 |
|
|
2019
Q2 | $2.02M | Buy |
31,380
+25,974
| +480% | +$1.67M | ﹤0.01% | 2811 |
|
|
2019
Q1 | $743K | Buy |
5,406
+1,944
| +56% | +$267K | ﹤0.01% | 3397 |
|
|
2018
Q4 | $313K | Sell |
3,462
-578
| -14% | -$52.3K | ﹤0.01% | 3582 |
|
|
2018
Q3 | $613K | Buy |
4,040
+428
| +12% | +$64.9K | ﹤0.01% | 3376 |
|
|
2018
Q2 | $621K | Buy |
3,612
+1,586
| +78% | +$273K | ﹤0.01% | 3431 |
|
|
2018
Q1 | $297K | Sell |
2,026
-451
| -18% | -$66.1K | ﹤0.01% | 3707 |
|
|
2017
Q4 | $502K | Buy |
2,477
+1,042
| +73% | +$211K | ﹤0.01% | 3456 |
|
|
2017
Q3 | $460K | Buy |
1,435
+269
| +23% | +$86.2K | ﹤0.01% | 3543 |
|
|
2017
Q2 | $263K | Sell |
1,166
-1,055
| -48% | -$238K | ﹤0.01% | 3858 |
|
|
2017
Q1 | $501K | Buy |
2,221
+443
| +25% | +$99.9K | ﹤0.01% | 3510 |
|
|
2016
Q4 | $352K | Buy |
1,778
+785
| +79% | +$155K | ﹤0.01% | 3634 |
|
|
2016
Q3 | $244K | Buy |
993
+263
| +36% | +$64.6K | ﹤0.01% | 3806 |
|
|
2016
Q2 | $424K | Sell |
730
-2,150
| -75% | -$1.25M | ﹤0.01% | 3417 |
|
|
2016
Q1 | $1.53M | Buy |
2,880
+1,824
| +173% | +$969K | ﹤0.01% | 2663 |
|
|
2015
Q4 | $741K | Buy |
1,056
+455
| +76% | +$319K | ﹤0.01% | 3046 |
|
|
2015
Q3 | $357K | Buy |
+601
| New | +$357K | ﹤0.01% | 3505 |
|